Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 16, Number 7—July 2010

Dispatch

Rickettsia felis–associated Uneruptive Fever, Senegal

Cristina Socolovschi, Oleg Mediannikov, Cheikh Sokhna, Adama Tall, Georges Diatta, Hubert Bassene, Jean-François Trape, and Didier RaoultComments to Author 
Author affiliations: Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes, Marseille, France (C. Socolovschi, O. Mediannikov, D. Raoult); Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes, Dakar, Senegal (O. Mediannikov, C. Sokhna, G. Diatta, H. Bassene, J.-F. Trape); Institut Pasteur de Dakar, Dakar (A. Tall)

Suggested citation for this article

Abstract

During November 2008–July 2009, we investigated the origin of unknown fever in Senegalese patients with a negative malaria test result, focusing on potential rickettsial infection. Using molecular tools, we found evidence for Rickettsia felis–associated illness in the initial days of infection in febrile Senegalese patients without malaria.

Flea-borne spotted fever is widely distributed throughout the world (1,2). The causative agent is Rickettsia felis, an obligate intracellular bacterium (2,3). Usually R. felis infection causes mild to moderate disease characterized by fever, cutaneous rash (sometimes with an inoculation eschar), and neurologic and digestive signs (13). The pathogen has been detected in numerous arthropods, but the main reservoirs are Ctenocephalides spp. fleas, which are ectoparasites of domestic cats and dogs (2). Mammals that carry fleas around humans contribute to accidental infection of humans with R. felis after flea bites (2,4).

R. felis infection is generally diagnosed on the basis of both serologic assays and bacterial DNA detection by PCR (24). In Africa, human R. felis infections have been reported in Tunisia (5) but not in Senegal. One case of murine typhus, induced by R. typhi, was reported in Spain in an immigrant from Senegal (6). Recently, the high incidence of rickettsial diseases was noted in international travelers from sub-Saharan Africa (7). However, because rickettsiosis often is misdiagnosed, in the incidence of arthropod-borne spotted fever in humans in Africa may be underestimated (4).

The objective of our study was to investigate the origin of unknown fever in Senegalese patients who had a negative test result for malaria. We focused on potential Rickettsia spp. infection as a cause of fever.

The Study

We conducted interviews and sampling during November 2008–July 2009 in 2 rural Senegalese villages in the Sine-Saloum region: Dielmo (13°43′N, 16°24′W) and Ndiop (13°41′N, 16°23′W) (8). The villages were included in a longitudinal prospective study, initiated in 1990, for investigations of host–parasite relationships (8,9). At the beginning of the study, all participants, including parents or legal guardians of all children, gave written individual informed consent. The national ethics committee of Senegal and the local ethics committee of Mediterranean University, Marseille, France, approved this project.

Medical examination and blood sampling were conducted for each person who had a fever >37.5°C. Approximately 200 µL (3–4 drops) of whole blood was collected from each patient by lancet stick of a fingertip for malaria tests and DNA extraction. Our study used only samples negative for Plasmodium spp. The first step of DNA extraction was conducted in the village dispensary by using the QIAamp kit (QIAGEN, Hilden, Germany). Binding and washing of samples with Qiagen columns was performed with an adapted manual pump (Fisher Scientific Inc, Strasbourg, France). Columns were stored at 4°C until final elution was performed in Marseille, France.

We screened 204 samples from 134 patients by quantitative real-time PCR (qPCR) for all spotted fever group rickettsiae with Rickettsia-specific gltA gene–based RKND03 system. Positive results were confirmed by a newly designed real-time PCR primer and probe combination based on the RC0338 gene (Table 1). Appropriate handling and DNA extraction are controlled by qPCR of the β-actin gene (Table 1). We analyzed data using Epi Info software, version 3.4.1 (Centers for Disease Control and Prevention, Atlanta, GA, USA).

A total of 103 patients were from Dielmo (391 inhabitants), and 31 were from Ndiop (313 inhabitants). Seventy-two patients were female, and 90 (67%) were >10 years of age. No one died during the study, and all patients with identified rickettsiae infection completely recovered.

We identified 9 samples from 8 patients (6%) positive by both genus-specific qPCR systems (Table 1). The following sequencing of nested PCR gltA gene amplicons from all positive samples showed 100% homology with R. felis URRWXCal2 (GenBank accession no. CP000053) (10). Furthermore, all positive samples were confirmed by R. felis species–specific qPCR. One girl 6 years age had 2 R. felis–positive blood samples 1.5 months apart. No samples were positive for typhus group rickettsiae, and 1 was was positive for R. conorii by sequencing of amplicons (data not shown).

The prevalence of flea-borne spotted fever in all tested samples was 4.4% (9/204). Monthly incidence for positive samples was 4.76% (1/21) in December, 4.76% (2/42) in January, 16.66% (3/18) in April, 6.89% (2/29) in June, and 2.38% (1/42) in July. Seven patients lived in Dielmo, and 1 lived in in Ndiop. The overall incidence was 1.7% in Dielmo and 0.3% in Ndiop (7/391 vs. 1/313; p = 0.06), and for children <10 years of age 3.5% (5/143) in Dielmo and 0.9% (1/109) in Ndiop. The incidence of flea-borne spotted fever was highest among children <10 years of age (6/252 vs. 2/452; p = 0.02). The average age of infected patients was 15 years (range 2–57 years). Clinical manifestations are detailed in Table 2. No rashes and no eschars were found during examination.

Conclusions

Our study provides molecular evidence for R. felis infection in West Africa in the initial days of infection in febrile Senegalese patients who did not have malaria. This infection can be easily misdiagnosed because it lacks specific signs (2,3). We developed a 2-step DNA extraction protocol from collected whole blood. The first step, directly performed in the rural villages far from standard laboratory facilities, improved sample storage and limited contamination. Accordingly, this eliminated the need to either mount a complete DNA extraction laboratory in the field or to transport fragile samples, such as human blood, from a remote site. This method can be used for research of other infectious diseases in rural area and in other developing countries.

The major clinical signs and symptoms in our study were fever associated with weakness, headache with sleep disorders, and digestive and respiratory signs; we also noted a lack of cutaneous rash or inoculation eschar (25). Another rickettsial study in an indigenous African population reported that cutaneous rash might be imperceptible in patients with pigmented skin (11).

Interestingly, a 6-year-old child had 2 positive blood samples for R. felis infection; the samples were taken at 1.5 month intervals, which raises the question of potential reinfection, chronic bacteremia, or relapse. Unfortunately, the girl was not treated with antimicrobial drugs between these episodes because the samples arrived together at the laboratory for molecular diagnosis. Relapses have been described for other rickettsial diseases such as epidemic typhus with late relapse (Brill-Zinsser disease) (12) and scrub typhus with early relapse (13). Our study identified a higher attack rate of flea-borne spotted fever in children <10 years of age with an attack rate of 3.5% in Dielmo during a 9-month period. Some reports of rickettsial diseases in sub-Saharan Africa indicate more infection in younger persons in whom the disease might be mild or subclinical (14).

The incidence of flea-borne spotted fever was higher in Dielmo than in Ndiop. Notably, tick-borne relapsing fever, malaria, and Q fever also are more prevalent in Dielmo than in Ndiop (8,9). Reasons for the significantly different prevalence of these infectious diseases in the 2 geographically close villages remain unexplained. Our preliminary work over 9 months did not determine a seasonal variation, but we noted more cases in April. Rickettsiae, including R. felis, have not been reported as background organisms that may circulate undetected in the blood of humans and thus be detected by chance. Nevertheless, future work on the clarification of the role of Rickettsia spp. in public health will include the study of healthy controls from appropriate cohorts.

Finally, we believe that the incidence of R. felis infection is largely underestimated and may be responsible in Africa for many cases of uneruptive fevers of unknown origin, including those associated with respiratory, digestive, and neurologic signs. We can speculate that flea-borne spotted fever might be an important neglected public health concern not only in North Africa but also in sub-Saharan Africa. Children are particularly vulnerable to this emerging infection.

Dr Socolovschi is an assistant professor of infectious diseases and tropical medicine at the Medical School of Marseilles, France. Her research interests focus on vector-borne infectious tropical diseases and medical entomology.

Acknowledgment

We are grateful to all patients who participated in this study, to Hervé Richet for help with statistical analysis, and to 2 anonymous reviewers who helped improve the manuscript.

References

  1. Parola P, Davoust B, Raoult D. Tick- and flea-borne rickettsial emerging zoonoses. Vet Res. 2005;36:46992. DOIPubMed
  2. Reif KE, Macaluso KR. Ecology of Rickettsia felis: a review. J Med Entomol. 2009;46:72336. DOIPubMed
  3. Renvoise A, Joliot AY, Raoult D. Rickettsia felis infection in man, France. Emerg Infect Dis. 2009;15:11267. DOIPubMed
  4. Raoult D, La Scola B, Enea M, Fournier PE, Roux V, Fenollar F, A flea-associated Rickettsia pathogenic for humans. Emerg Infect Dis. 2001;7:7381. DOIPubMed
  5. Znazen A, Rolain JM, Hammami A, Jemaa MB, Raoult D. Rickettsia felis infection, Tunisia. Emerg Infect Dis. 2006;12:13840.PubMed
  6. Angel-Moreno A, Bolanos M, Santana E, Perez-Arellano JL. Murine typhus imported from Senegal in a travelling immigrant [in Spanish]. Enferm Infecc Microbiol Clin. 2006;24:4067.PubMed
  7. Jensenius M, Davis X, von SF, Schwartz E, Keystone JS, Leder K, et al. Multicenter GeoSentinel analysis of rickettsial diseases in international travelers, 1996–2008. Emerg Infect Dis. 2009;15:17918.PubMed
  8. Trape JF, Rogier C, Konate L, Diagne N, Bouganali H, Canque B, The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. Am J Trop Med Hyg. 1994;51:12337.PubMed
  9. Vial L, Diatta G, Tall A, Ba el H, Bouganali H, Durand P, et al. Incidence of tick-borne relapsing fever in west Africa: longitudinal study. Lancet. 2006;368:3743. DOIPubMed
  10. Mediannikov OY, Sidelnikov Y, Ivanov L, Mokretsova E, Fournier PE, Tarasevich I, Acute tick-borne rickettsiosis caused by Rickettsia heilongjiangensis in Russian Far East. Emerg Infect Dis. 2004;10:8107.PubMed
  11. Raoult D, Ndihokubwayo JB, Tissot-Dupont H, Roux V, Faugere B, Abegbinni R, Outbreak of epidemic typhus associated with trench fever in Burundi. Lancet. 1998;352:3538. DOIPubMed
  12. Bechah Y, Paddock CD, Capo C, Mege JL, Raoult D. Adipose tissue serves as a reservoir for recrudescent Rickettsia prowazekii infection in a mouse model. PLoS ONE. 2010;5:e8547. DOIPubMed
  13. Phongmany S, Rolain JM, Phetsouvanh R, Blacksell SD, Soukkhaseum V, Rasachack B, Rickettsial infections and fever, Vientiane, Laos. Emerg Infect Dis. 2006;12:25662.PubMed
  14. Jensenius M, Fournier PE, Kelly P, Myrvang B, Raoult D. Afican tick bite fever. Lancet Infect Dis. 2003;3:55764. DOIPubMed

Tables

Suggested citation for this article: Socolovschi, C, Mediannikov O, Sokhna C, Tall A, Diatta G, Bassene H, et al. Rickettsia felis–associated uneruptive fever, Senegal. Emerg Infect Dis [serial on the Internet]. 2010 Jul [date cited]. http://wwwnc.cdc.gov/eid/article/16/7/10-0070.htm

DOI: 10.3201/eid1607.100070

Top of Page

Table of Contents – Volume 16, Number 7—July 2010

Comments to the Authors

Please use the form below to submit correspondence to the authors or contact them at the following address:

Didier Raoult, Unité de Recherche en Maladies Infectieuses et Tropicales Emergentes (URMITE), UMR CNRS-IRD 6236-198, Faculté de Médecine, 27 Bd Jean Moulin, 13385 Marseille CEDEX 5, France





characters(s) remaining.

Comment submitted successfully, thank you for your feedback.

Comments to the EID Editors

Please contact the EID Editors via our Contact Form.

 

Past Issues

Select a Past Issue:

World Malaria Day - April 25, 2014 - Invest in the future, defeat malaria

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO